NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trials for the treatment of non-alcoholic steatohepatitis (NASH); and MK-3655, an agonistic antibody that activates fibroblast growth factor receptor 1c-beta-klotho, which is in Phase IIb clinical trials for use in the treatment of type 2 diabetes and NASH. Its products under development also comprise NGM120, an antagonist antibody that binds GFRAL that is in Phase I/II clinical trials; NGM621, an immunoglobulin 1 monoclonal antibody in Phase II clinical trials for the treatment of geographic atrophy; NGM707, an immunoglobulin-like transcript 2/ immunoglobulin-like transcript 4 dual antagonist monoclonal antibody that is in Phase I/II clinical trials for the treatment of patients with advanced solid tumors; and NGM831 and NGM438 for the treatment of advanced solid tumors. The company has research collaboration, product development, and license agreements with Merck Sharp & Dohme Corp.; and a collaboration agreement with Merck & Co., Inc. to focus primarily on the development of novel medicines for unmet patient needs in retinal and CVM diseases, including heart failure. NGM Biopharmaceuticals, Inc. was incorporated in 2007 and is headquartered in South San Francisco, California. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of NGM Biopharmaceuticals Inc..
NGM Biopharmaceuticals Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of NGM Biopharmaceuticals Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of NGM Biopharmaceuticals Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of NGM Biopharmaceuticals Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of NGM Biopharmaceuticals Inc. and all latest updates of the company are provided.
The 2025 version of NGM Biopharmaceuticals Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 NGM Biopharmaceuticals Inc.- Key Facts
2.2 NGM Biopharmaceuticals Inc.- Geographic Locations
2.3 NGM Biopharmaceuticals Inc.- Subsidiaries and Affiliates
2.4 NGM Biopharmaceuticals Inc.- Business Divisions
2.5 NGM Biopharmaceuticals Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. NGM Biopharmaceuticals Inc. Strategic Analysis Review
3.1 NGM Biopharmaceuticals Inc.- Key Strategies
3.2 NGM Biopharmaceuticals Inc.- Company Outlook Statement
3.3 NGM Biopharmaceuticals Inc.- SWOT Analysis
3.3.1 NGM Biopharmaceuticals Inc.- Key Strengths
3.3.2 NGM Biopharmaceuticals Inc.- Key Weaknesses
3.3.3 NGM Biopharmaceuticals Inc.- Potential Opportunities
3.3.4 NGM Biopharmaceuticals Inc.- Potential Threats
3.4 NGM Biopharmaceuticals Inc.- Key Competitors
4. Business Description of the Company
4.1 NGM Biopharmaceuticals Inc.- Business Overview
4.2 NGM Biopharmaceuticals Inc.- Operations by Segment
5 Products and Services Details
5.1 NGM Biopharmaceuticals Inc.- Key Products
5.2 NGM Biopharmaceuticals Inc.- Key Service Areas
5.3 NGM Biopharmaceuticals Inc.- Key Brands
6 Company Developments
6.1 NGM Biopharmaceuticals Inc.- Company History
6.2 NGM Biopharmaceuticals Inc.- Latest Developments
7 Financial Analysis
7.1 NGM Biopharmaceuticals Inc.- Income Statements
7.2 NGM Biopharmaceuticals Inc.- Balance Sheet
7.3 NGM Biopharmaceuticals Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 NGM Biopharmaceuticals Inc.- Direct Competitors
8.2 NGM Biopharmaceuticals Inc.- Competitor Financial Ratios comparison
8.3 NGM Biopharmaceuticals Inc.- Competitor Stock Charts Comparison
8.4 NGM Biopharmaceuticals Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
